European Psychiatry · 2014 · 17 citations · 17 references
Life SciencesNeurosciencePsychiatryGene ExpressionNeurogeneticsNeuropsychiatryGenomic ProfilingMolecular NeurogeneticsNeuropsychiatric GeneticsPsychiatric GeneticsSchizophrenia Spectrum DisordersDopamine Receptor SubtypesDopamine-dependent Gene ExpressionDopaminergic ModulationDopaminergic PathwaysEtiology Of Psychotic DisordersPsychiatric Genetic RiskPsychiatric GenomicsSchizophrenia Genetics
Psychosis-proneness or schizotypy is a personality organisation mirroring individual risk for schizophrenia-development. Believed to be a fully dimensional construct sharing considerable geno- and phenotypal variance with clinical schizophrenia, it has become an increasingly promising tool for basic psychosis-research. Although many studies show genetic commonalities between schizotypy and schizophrenia, changes in regulation of gene expression have never been examined in schizotypy before. We therefore extracted RNA from the blood, a valid surrogate for brain tissue, of a large sample of 67 healthy male volunteers and correlated the activities of all genes relevant for dopaminergic neurotransmission with the positive schizotypy-scale of the O-LIFE. We found significant negative correlations regarding the expression of the genes COMT, MAOB, DRD4, DRD5 and FOS, indicating that increased schizotypy coincides with higher levels of dopaminergic dysregulation on the mRNA-level. Considering the advantages of this method, we suggest that it be applied more often in fundamental psychosis-research.
17
Phillip Grant, Yvonne Kuepper, E. Mueller et al. · Frontiers in Human Neuroscience · 2013 · 716 citations · Full text
Medicine, Psychiatry, Psychology +17
Stephen J. Glatt, Ian Everall, William S. Kremen et al. · Proceedings of the National Academy of Sciences · 2005 · 345 citations · Full text